• infusion
  • Six patients were enrolled in the study, four of whom received infusion of genetically altered cells (one patient mobilized insufficient HSCs, and the other developed early progressive disease). (biomedcentral.com)
  • toxicity
  • If a patient's hematopoetic system was reconstituted using cells containing this gene, then there is the potential to further treat the patient with drugs such as paclitaxel without causing significant hematopoietic toxicity. (biomedcentral.com)
  • Hodgkin's
  • The purpose of this study is to assess the tolerability, pharmacokinetics and antitumor effect of bendamustine hydrochloride (SyB L-0501) in patients with indolent B-cell Non-Hodgkin's Lym. (bioportfolio.com)
  • donor
  • Finally, although the remaining host T cells displayed a proinflammatory phenotype following ABMT, IFNγ, IL-17, and TNFα production by the newly reconstituted donor-derived T cells was significantly lower. (sigmaaldrich.com)